Ifp Advisors, Inc Celldex Therapeutics, Inc. Transaction History

Ifp Advisors, Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	SELL	$27.78 - $45.38 $277 - $453	-10 Reduced 34.48%	19 $2,000
Q2 2022 Sep 06, 2022	BUY	$20.5 - $37.33 $594 - $1,082	29 New	29 $4,000
Q2 2022 Aug 12, 2022	SELL	$20.5 - $37.33 $594 - $1,082	-29 Closed	0 $0
Q1 2022 Sep 06, 2022	BUY	$27.64 - $39.32 $801 - $1,140	29 New	29 $0
Q4 2019 Jan 17, 2020	SELL	$2.11 - $2.8 $10 - $14	-5 Closed	0 $0
Q3 2019 Nov 07, 2019	BUY	$2.05 - $2.75 $10 - $13	5 New	5 $0

197

66M

1.68M

980K

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.05B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.